The Pain Quality Response Profile of Pregabalin in the Treatment of Neuropathic Pain
Mark P. Jensen(University of Washington), David Hewitt(Glasgow Royal Infirmary), Bradley S. Galer(Rapt Therapeutics (United States)), Steven S. Smugar(Merck & Co., Inc., Rahway, NJ, USA (United States)), Achilles Alon(Merck & Co., Inc., Rahway, NJ, USA (United States)), Arnold R. Gammaitoni(Merck & Co., Inc., Rahway, NJ, USA (United States)), James A. Bolognese(Cytel (United States))
Cited by 18
Related Papers
Advances in Neuropathic Pain
|Archives of Neurology|2003|1.2k
Sources of variance in 24-hour dietary recall data: implications for nutrition study design and interpretation
|American Journal of Clinical Nutrition|1979|997
MALIGNANT DISEASE IN CHILDHOOD AND DIAGNOSTIC IRRADIATION IN UTERO
|The Lancet|1956|569
A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications
|British Journal of Anaesthesia|2018|432